Welcome to our dedicated page for DURECT SEC filings (Ticker: DRRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DURECT Corporation filings document the regulatory record of a biopharmaceutical issuer whose disclosures centered on larsucosterol development, operating results, material agreements, capital structure, governance matters, and clinical or regulatory updates. The company's 8-K reports include financial-results releases, Regulation FD disclosures, material definitive agreements, and completed corporate-transaction records.
Later filings document DURECT's corporate-status transition, including Form 25 notification for removal of its common stock from Nasdaq listing and Form 15 certification terminating registration or suspending reporting obligations under the Exchange Act. Those records identify the common stock covered by the filings and the resulting public-company reporting status.
Durect Corporation filed an S-8 registration statement listing numerous prior S-8 filings and registrations of common stock for employee plans spanning 2000 through 2024. The filing enumerates specific share amounts reserved under various plans (including Employee Stock Purchase Plans, Stock Plans, Directors' Stock Option Plan and legacy plans) and notes a 1-for-10 reverse stock split effected December 5, 2022, with several later registrations stated as ‘‘after giving effect’’ to that split.
Durect Corporation filed an S-8 post-effective amendment that lists prior registration statements and the number of common shares registered for various employee plans dating from 2000 through November 14, 2024. The filing documents multiple past registrations under the 1998 Incentive Stock Plan, the 2000 Employee Stock Purchase Plan and the 2000 Stock Plan (and related director/legacy plans), and notes a 1-for-10 reverse stock split effected December 5, 2022. The document also identifies the company as incorporated in Delaware and includes an EIN and signature by the CFO, Timothy M. Papp.
Durect Corporation (DRRX) filed an S-8 post-effective amendment listing prior S-8 registration statements and the number of shares reserved under various employee equity plans over time. The filing documents multiple historical registrations dating from October 5, 2000 through November 14, 2024, including registrations under the 1998 Incentive Stock Plan, the 2000 Employee Stock Purchase Plan, the 2000 Stock Plan and director/legacy plans. The filing also notes a 1-for-10 reverse stock split effective December 5, 2022.
Durect Corporation (DRRX) filed an S-8 post-effective amendment listing prior S-8 registration statements and the amounts of common stock registered under various employee plans over time. The filing documents multiple historical registrations (ranging from tens of thousands to millions of shares) for stock option plans and employee stock purchase plans, notes a 1-for-10 reverse stock split effective December 5, 2022, and is signed by the CFO.